4.7 Article

Gene-specific DNA methylation in newborns in response to folic acid supplementation during the second and third trimesters of pregnancy: epigenetic analysis from a randomized controlled trial

Journal

AMERICAN JOURNAL OF CLINICAL NUTRITION
Volume 107, Issue 4, Pages 566-575

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ajcn/nqx069

Keywords

folic acid; pregnancy; DNA methylation; epigenetics

Funding

  1. HSC (Health and Social Care) Research and Development Division of the Public Health Agency, Northern Ireland [STL/5043/14]
  2. Biology and Biological Sciences Research Council (BBSRC) [ES/N000323/1]
  3. Economic and Social Research Council (ESRC) [ES/N000323/1]
  4. ESRC [ES/N000323/1] Funding Source: UKRI
  5. MRC [MR/J007773/1] Funding Source: UKRI
  6. Economic and Social Research Council [ES/N000323/1] Funding Source: researchfish
  7. Medical Research Council [MR/J007773/1] Funding Source: researchfish
  8. Public Health Agency [STL/5043/14] Funding Source: researchfish

Ask authors/readers for more resources

Emerging evidence suggests that maternal folate status can impact cognitive development in childhood. Folate-dependent DNA methylation may provide a biological mechanism to link folate status during pregnancy with cognition in the offspring. The objective was to investigate the effect of continued folic acid (FA) supplementation beyond the first trimester of pregnancy on DNA methylation in cord blood of epigenetically controlled genes related to brain development and function. Using available cord blood samples (n = 86) from the Folic Acid Supplementation in the Second and Third Trimesters (FASSTT) trial in pregnancy, we applied pyrosequencing techniques to analyze cord blood DNA at 9 candidate loci known to be regulated by methylation, including some previously implicated in observational studies: the widely dispersed retrotransposon long interspersed nuclear element-1 (LINE-1) and 8 single-copy loci (RBM46, PEG3, IGF2, GRB10, BDNF, GRIN3B, OPCML, andAPC2). The newborns of mothers who received ongoing FA (400 A mu g/d) through the second and third trimesters, compared with placebo, had significantly lower overall DNA methylation levels at LINE-1 (56.3% +/- 1.7% compared with 57.2% +/- 2.1%;P = 0.024),IFG2 (48.9% +/- 4.4% compared with 51.2% +/- 5.1%;P = 0.021), andBDNF (2.7% +/- 0.7% compared with 3.1% +/- 0.8%;P = 0.003). The effect of FA treatment on DNA methylation was significant only in female offspring forIGF2 (P = 0.028) and only in males forBDNF (P = 0.012). ForGRB10 andGRIN3B, we detected no effect on overall methylation; however, individual cytosine-phosphate-guanine sites showed significant DNA methylation changes in response to FA. Continued supplementation with FA through trimesters 2 and 3 of pregnancy results in significant changes in DNA methylation in cord blood of genes related to brain development. The findings offer a potential biological mechanism linking maternal folate status with neurodevelopment of the offspring, but this requires further investigation using a genome-wide approach. This trial was registered at www.isrctn.com as ISRCTN19917787.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available